Last updated: March 12, 2026
What is NDC 69230-0318?
This National Drug Code (NDC) corresponds to [specific drug name, dosage, and form—if available]. It is a [prescription/over-the-counter] medication primarily indicated for [main therapeutic use]. The drug’s approval status, manufacturing details, and regulatory environment influence its market dynamics.
Market Overview
Therapeutic Area and Competitive Landscape
- Therapeutic Category: [e.g., Oncology, Cardiology, Infectious Disease]
- Market Size: The global market for this class is estimated at [$X billion], expected to grow at CAGR of [X%] over the next 5 years.
- Key Competitors: Includes [major competitors/products], with market shares roughly [percentage breakdown].
Regulatory Status
- [FDA approval date and status]
- If applicable, recent label expansions or reductions
- Patent protection or exclusivity periods
Market Drivers
- Rising prevalence of [target condition]
- Advances in formulation or delivery (e.g., long-acting, combining drugs)
- Reimbursement policies favoring new treatment options
Market Barriers
- High drug development and manufacturing costs
- Competitive generic entry post-patent expiry
- Pricing pressures from payers and pharmacy benefit managers
Price Trends and Historical Data
Current Price Points
| Region |
Average Wholesale Price (AWP) |
Estimated List Price |
Typical Reimbursement Range |
| US |
$[value] |
$[value] |
$[value] - $[value] |
| EU |
€[value] |
€[value] |
€[value] - €[value] |
| Other |
[local currency] |
[local currency] |
[local currency] - [local currency] |
Historical Pricing
- Since [year], the drug's list price increased by [X%], driven by [cost inflation, formulation improvements, label expansions].
- Post-approval, initial prices ranged from $[low] to $[high] per unit.
Price Adjustments
- Recent formulary negotiations reduced reimbursement rates by [X%], impacting net prices.
- Patent or exclusivity expiry projected in [year], with subsequent price erosion expected due to generics or biosimilars.
Price Projections (Next 5 Years)
| Year |
Estimated Average Price |
Key Factors Impacting Price |
Notes |
| 2023 |
$[value] |
Market growth, inflation |
Slight increase expected |
| 2024 |
$[value] |
Patent expiry, competition |
Possible price decline due to generics |
| 2025 |
$[value] |
Contract negotiations |
Stabilization at a lower level |
| 2026 |
$[value] |
Regulatory changes |
Price adjustments depending on policy |
| 2027 |
$[value] |
New formulations or indications |
Potential for price rise with new uses |
Factors Influencing Future Pricing
- Expiration of patent or exclusivity rights
- Entry of biosimilars or generics
- Changes in reimbursement policies
- Manufacturing cost variations
- Adoption of biosimilar or lower-cost alternatives
Market Opportunities and Risks
Opportunities
- Introduction of combination therapies increasing use
- Expansion into new indications or geographies
- Off-label uses driven by clinical research
Risks
- Price regulation policies constraining profit margins
- Price erosion from generic competition
- Shifts in payer policies favoring cost-effective options
Key Takeaways
- The drug faces typical patent and market entry challenges once exclusivity ends.
- Current US list prices are approximately $[value] per unit, with anticipated declines post-patent.
- Market growth depends on therapeutic demand, regulatory approvals, and competitive landscape changes.
- Competitive pressures and policy shifts will likely drive prices down over the next five years.
- Monitoring patent expiry dates and biosimilar developments is critical for accurate pricing forecasts.
FAQs
Q1: What influences the drug’s pricing in the US compared to other regions?
Pricing is driven by reimbursement policies, regional regulatory standards, and discount negotiations, with the US typically having higher list prices but more comprehensive payer negotiations.
Q2: How will patent expiration affect prices?
Patent expiry generally leads to a significant reduction in price, often by 30-50%, due to the entry of generics or biosimilars.
Q3: Are there recent regulatory changes impacting pricing strategies?
Yes, recent price transparency and negotiation policies may force reductions, especially in public payers like Medicaid.
Q4: What are the main drivers for future price increases?
Introduction of new indications, formulation improvements, or combination therapies can justify price increases.
Q5: How does market competition impact long-term profitability?
Entry of biosimilars or generics can halve or more than halve the drug’s price, affecting profitability and market share.
Sources
[1] U.S. Food and Drug Administration (FDA). (2022). Approved drug list.
[2] IQVIA. (2022). National Prescription Audit.
[3] Medicare Pricing Data. (2022).
[4] Analyst Reports on [Specific Therapeutic Area].
[5] Company filings and patent databases.
(Note: Data points such as prices and market sizes should be updated with current data from reliable sources, as this report is based on assumptions and general market trends.)
